Cardiac Fibroma


Article Author:
Furqan Rajput


Article Editor:
Faten Limaiem


Editors In Chief:
David Wood
Andrew Wilt
Mary Cataletto


Managing Editors:
Avais Raja
Orawan Chaigasame
Carrie Smith
Abdul Waheed
Khalid Alsayouri
Trevor Nezwek
Radia Jamil
Patrick Le
Anoosh Zafar Gondal
Saad Nazir
William Gossman
Hassam Zulfiqar
Steve Bhimji
John Shell
Matthew Varacallo
Heba Mahdy
Ahmad Malik
Sarosh Vaqar
Mark Pellegrini
James Hughes
Beata Beatty
Nazia Sadiq
Hajira Basit
Phillip Hynes
Tehmina Warsi


Updated:
6/18/2019 3:33:54 AM

Introduction

Primary cardiac tumors are rare, 75% are benign and have a reported incidence of 0.03–0.32%.[1][2][3][4] Cardiac fibromas are the second most common primary cardiac tumor after rhabdomyoma in children. They are primarily composed of connective tissue and fibroblast and although benign, can be symptomatic due to intracavitary obstruction, inflow and outflow tract obstruction, coronary artery compromise, thromboembolic events, conduction defects, and can also lead to sudden death.[5][6][4] Pediatric cardiac tumors carry associations with genetic conditions, for example, rhabdomyomas have an association with tuberous sclerosis, and about 3% of patients with nevoid basal cell carcinoma syndrome (NBCCS), also called Gorlin syndrome, have cardiac fibromas.[7][8]

Etiology

Gorlin syndrome exists as an autosomal dominant, multisystem disorder due to mutations in the PTCH1 or SUFU tumor suppressor genes which has a prevalence of 1/31,000 to 1/164,000; mostly inherited from an affected parent but can also arise de novo in 20–30% cases. 

Epidemiology

Cardiac fibroma is a tumor that primarily affects children. Most cases are detected in infants or in utero. Cardiac fibromas typically present in infancy, but in patients with NBCCS, they have been reported to develop up to the age of 60 years.[9] They are the second most common benign cardiac tumor in children (after rhabdomyoma), and the second most common in fetuses, because of prenatal diagnosis.[10] There is a slight male predominance.

Pathophysiology

The most common site is the left ventricle (approximately 57% of the cases), followed by right ventricle (27.5%), and interventricular septum (17%). There is a hypothesis that the tumor increases in size with physiological cardiac growth and stops growing when the growth of the heart completes, usually at 17 to 20 years of age. Hence, with somatic growth, the size of fibroma decreases relative to cardiac mass, but unlike rhabdomyoma, fibromas never resolve completely. Septal involvement and age less than 17 years old at the time of diagnosis are associated with a poor prognosis. It is probably because younger patients have a smaller heart and high tumor-to-heart ratio compared to older individuals, generating low cardiac output leading to poor outcomes.[10] Fibromas involving interventricular septum frequently induce conduction system disease with resulting rhythm abnormalities.

In contrast to cardiac rhabdomyoma, cardiac fibroma rarely regress spontaneously and often present with arrhythmias (32%), mostly ventricular tachycardia (risk exceeding 50%), ventricular fibrillation, murmur (20%), and abnormal chest x-ray (20%).[4] Coronary arteries are usually not involved, but there have been reports of coronary compression by large fibromas.

Histopathology

Histopathology:

Cardiac fibroma is composed of monomorphic fibroblasts that demonstrate little or no atypia.[11] The margins infiltrate into cardiac muscle. The degree of cellularity often decreases with the age of the patient, and the amount of collagen increases. Mitoses are generally present only in tumors occurring in infants. There can be occasional perivascular aggregates of lymphocytes and histiocytes or sparse chronic inflammation at the junction of the tumor and uninvolved myocardium. Calcification is a common finding with these fibromas in patients of all ages.[12]

Immunohistochemistry:

The tumor cells show myofibroblastic differentiation and are positive for vimentin and smooth muscle actin, whereas CD34, S100, and HMB45 are negative.[13][12]

History and Physical

Cardiac fibromas may be asymptomatic. Common presentations of cardiac fibromas include[14]:

  • Heart murmurs,
  • Arrhythmias,
  • Congestive heart failure,
  • Sudden death.

Nevoid basal cell carcinoma syndrome carries associations with lamellar or early calcification of the falx, jaw keratocysts, palmar and plantar pits, with a predisposition for basal cell carcinomas. Characteristic facial features include macrocephaly, frontal bossing, and hypertelorism. Skeletal anomalies, early childhood medulloblastoma, cleft lip/ palate, and there are reports of ovarian fibromas in female patients with NBCCS.[15] 

Evaluation

Imaging using magnetic resonance imaging (MRI) shows an encapsulated mass with no vascularization and delayed enhancement. Histology is not always a requirement for diagnosis in the presence of clinical phenotype and MRI findings. Electrocardiogram (ECG) in most fibroma patients shows T-wave abnormalities, and VT morphologies on ECG are mostly consistent with an origin near the tumor site. In adults, it is also reported to present as a fixed defect on myocardial perfusion imaging.[9]

Treatment / Management

Due to the rarity of cardiac fibromas (1 in 280,000 births), the best clinical management is not yet well defined, and it presents as a challenging entity for pediatric cardiologists. Suggestions for different management strategies exist in the literature including surgical resection, single ventricle palliation, cardiac transplant, and even conservative treatment with antiarrhythmic medications.

Defibrillator placement to prevent malignant arrhythmia after cardiac arrest is associated with a high risk of complications in infants and should only be considered after exploring all options with the risks and benefits explained to the parents. One of the common strategies is to place an endocardial defibrillator lead around the back of the heart in the epicardial space and use epicardial pace/sense leads. Alternatively, use epicardial pace/sense leads and tunnel an endocardial defibrillator lead along the intercostal space is also a reported option. With epicardial defibrillator, the risk of lead fracture is high with a reported 5-year failure rate of 50%.[16]

Medical management with amiodarone and beta-blockers seems to be effective. Small and apically located fibromas respond well to antiarrhythmic medications and are probably better managed without defibrillators. Surgical resection has shown to provide curative treatment, alleviating the need for a defibrillator and long-term antiarrhythmic medications. It is also a viable treatment for large fibromas with positive results. A significant hurdle is the rarity of cardiac centers with experience in removing these tumors. Optimal time reported for surgery is between 1 to 3 years. Factors like the severity of arrhythmias, medication tolerance, defibrillation lead integrity, and symptoms are often considerations and dictate the appropriate time for surgery. Location and size of the tumor can complicate surgery, but even for large fibromas operative morbidity and mortality are low. Given that there are a limited number of patients, it is difficult to test the comparative effectiveness of these treatments.[16]

In patients with tumors not amenable to resection owing to its size and extensive involvement of cardiac structures, several reported cases of “single ventricle palliation” exist. In one case with a large right ventricle fibroma, single ventricle palliation was performed by doing balloon atrial septostomy, placement of a systemic-to-pulmonary shunt to allow an unobstructed venous return to the left atrium and left ventricle to support both systemic and pulmonary circulations. This and other methods of ventricle palliation provided a bridge to heart transplantation.[17]

Differential Diagnosis

Differentials include cardiac rhabdomyoma, myxoma, teratoma, lipoma, and hemangioma.  

Prognosis

Cardiac fibromas in infancy that are not surgically resectable because of size and extensive myocardial infiltration have a poor prognosis and may require defibrillator implantation or cardiac transplantation.[18] Tumors that can are resectable (even incompletely) have a good prognosis. In one study, the median survival of patients with cardiac fibromas after successful surgery was 27 years.[19]

Complications

 If cardiac fibromas are left untreated, there is an increase in the risk of fatality, particularly due to lethal ventricular arrhythmia.

Consultations

New diagnosis of NBCCS should obtain referrals to dermatologists, pediatricians, and geneticists, obstetrics-gynecology and psychology evaluations to implement cancer surveillance as per guidelines and early identification of potential complications.[8]

Deterrence and Patient Education

Because of a predisposition to basal cell carcinoma, patients with NBCCS  are encouraged to apply sunscreen, limit sun exposure, and avoid ionizing radiation.

Pearls and Other Issues

 

 

Enhancing Healthcare Team Outcomes

Nevoid basal cell carcinoma syndrome, given its wide phenotypic variations, is challenging to diagnose and needs a high level of suspicion to achieve prompt and early diagnosis. In sporadic cases, diagnosing NBCCS in proband should trigger genetic testing of other family members. Once identified, management implications include appropriate cancer screening and precautions, for example, screening for basal cell carcinoma (with encouragement to apply sunscreen, limit sun exposure and avoid ionizing radiation) and early childhood medulloblastoma (children less than eight years of age are recommended to have annual brain MRI with contrast). Diagnosis of cardiac fibroma, which rarely is a presenting manifestation, should prompt an evaluation for NBCCS along with a careful assessment of the patient’s past medical and family history. 

As mentioned earlier, patients diagnosed with NBCCS are at an increased risk of benign and malignant neoplasms at an early stage. Experts have recommended coordinated multispecialty care for surveillance of NBCCS patients.[20] [V-Case series, studies with no controls and expert opinion]


Interested in Participating?

We are looking for contributors to author, edit, and peer review our vast library of review articles and multiple choice questions. In as little as 2-3 hours you can make a significant contribution to your specialty. In return for a small amount of your time, you will receive free access to all content and you will be published as an author or editor in eBooks, apps, online CME/CE activities, and an online Learning Management System for students, teachers, and program directors that allows access to review materials in over 500 specialties.

Improve Content - Become an Author or Editor

This is an academic project designed to provide inexpensive peer-reviewed Apps, eBooks, and very soon an online CME/CE system to help students identify weaknesses and improve knowledge. We would like you to consider being an author or editor. Please click here to learn more. Thank you for you for your interest, the StatPearls Publishing Editorial Team.

Cardiac Fibroma - Questions

Take a quiz of the questions on this article.

Take Quiz
What is the most common presentation of a cardiac fibroma?



Click Your Answer Below


Would you like to access teaching points and more information on this topic?

Improve Content - Become an Author or Editor and get free access to the entire database, free eBooks, as well as free CME/CE as it becomes available. If interested, please click on "Sign Up" to register.

Purchase- Want immediate access to questions, answers, and teaching points? They can be purchased above at Apps and eBooks.


Sign Up
Diagnosis of cardiac fibroma should prompt evaluation for which genetic syndrome?



Click Your Answer Below


Would you like to access teaching points and more information on this topic?

Improve Content - Become an Author or Editor and get free access to the entire database, free eBooks, as well as free CME/CE as it becomes available. If interested, please click on "Sign Up" to register.

Purchase- Want immediate access to questions, answers, and teaching points? They can be purchased above at Apps and eBooks.


Sign Up
An 8-year-old boy presented to the emergency department accompanied by his parents with the complaints of progressively worsening shortness of breath both at rest and on exertion. He was diagnosed with Gorlin syndrome and is under active surveillance for basal cell skin cancers. Recurrent syncopal episodes lead to extensive workup including cardiac MRI which revealed a myocardial mass measuring 2 x 3 cm with well-defined borders originating from the left ventricle. He was started on amiodarone for ventricular arrhythmias 2 weeks ago and has had no syncopal episodes since then. Chest x-ray shows pulmonary edema. Considering the diagnosis of cardiac fibroma, what is the most common cause of the patient's symptoms?



Click Your Answer Below


Would you like to access teaching points and more information on this topic?

Improve Content - Become an Author or Editor and get free access to the entire database, free eBooks, as well as free CME/CE as it becomes available. If interested, please click on "Sign Up" to register.

Purchase- Want immediate access to questions, answers, and teaching points? They can be purchased above at Apps and eBooks.


Sign Up
A 23-year-old man presented with a three-month history of cough and shortness of breath. Electrocardiogram indicated normal sinus rhythm, and physical examination revealed normal blood pressure and regular pulse. Echocardiography revealed a large mass located in the left ventricular lateral wall. Cardiac magnetic resonance imaging (MRI) indicated a large mass located in the lateral wall of the left ventricle. The mass was regular and well defined, with a size of 8×5×4 cm. The mass was T1 iso-intense compared with cardiac muscle and T2 hypo-intense compared with cardiac muscle. The patient underwent surgical excision of the tumor under standard cardiopulmonary bypass, and median sternotomy was performed. Grossly, the tumor was well-circumscribed, firm and white. Histopathological examination of the surgical specimen revealed a tumor proliferation composed of monomorphic fibroblasts set in a collagenous matrix. There were no atypia and no mitotic figures. The periphery of the tumor interdigitated with cardiac muscle. What is the most likely diagnosis?



Click Your Answer Below


Would you like to access teaching points and more information on this topic?

Improve Content - Become an Author or Editor and get free access to the entire database, free eBooks, as well as free CME/CE as it becomes available. If interested, please click on "Sign Up" to register.

Purchase- Want immediate access to questions, answers, and teaching points? They can be purchased above at Apps and eBooks.


Sign Up

Cardiac Fibroma - References

References

Cardiac Fibroma with Ventricular Tachycardia: An Unusual Clinical Presentation of Nevoid Basal Cell Carcinoma Syndrome., Ritter AL,Granquist EJ,Iyer VR,Izumi K,, Molecular syndromology, 2018 Jul     [PubMed]
Ventricular fibromas in children, arrhythmia risk, and outcomes: A multicenter study., Jones JP,Ramcharan T,Chaudhari M,Bhole V,Mcleod K,Sadagopan S,Uzun O,Parry A,Till J,McMahon CJ,Stuart AG,Walsh MA,, Heart rhythm, 2018 Jun 12     [PubMed]
Nadas AS,Ellison RC, Cardiac tumors in infancy. The American journal of cardiology. 1968 Mar     [PubMed]
Simcha A,Wells BG,Tynan MJ,Waterston DJ, Primary cardiac tumours in childhood. Archives of disease in childhood. 1971 Aug     [PubMed]
Isaacs H Jr, Fetal and neonatal hepatic tumors. Journal of pediatric surgery. 2007 Nov     [PubMed]
Miyake CY,Del Nido PJ,Alexander ME,Cecchin F,Berul CI,Triedman JK,Geva T,Walsh EP, Cardiac tumors and associated arrhythmias in pediatric patients, with observations on surgical therapy for ventricular tachycardia. Journal of the American College of Cardiology. 2011 Oct 25     [PubMed]
Burke AP,Rosado-de-Christenson M,Templeton PA,Virmani R, Cardiac fibroma: clinicopathologic correlates and surgical treatment. The Journal of thoracic and cardiovascular surgery. 1994 Nov     [PubMed]
Becker AE, Primary heart tumors in the pediatric age group: a review of salient pathologic features relevant for clinicians. Pediatric cardiology. 2000 Jul-Aug     [PubMed]
Gorlin RJ, Nevoid basal cell carcinoma (Gorlin) syndrome. Genetics in medicine : official journal of the American College of Medical Genetics. 2004 Nov-Dec     [PubMed]
Evans DG,Howard E,Giblin C,Clancy T,Spencer H,Huson SM,Lalloo F, Birth incidence and prevalence of tumor-prone syndromes: estimates from a UK family genetic register service. American journal of medical genetics. Part A. 2010 Feb     [PubMed]
Pittman S,Sethi P,Flavell RR,Pampaloni MH, Cardiac Fibroma: An Uncommon Cause of a Fixed Defect on Myocardial Perfusion Imaging. Clinical nuclear medicine. 2018 Feb     [PubMed]
Torimitsu S,Nemoto T,Wakayama M,Okubo Y,Yokose T,Kitahara K,Ozawa T,Nakayama H,Shinozaki M,Sasai D,Ishiwatari T,Takuma K,Shibuya K, Literature survey on epidemiology and pathology of cardiac fibroma. European journal of medical research. 2012 Mar 27     [PubMed]
Waller BR,Bradley SM,Crumbley AJ 3rd,Wiles HB,McQuinn TC,Bennett AT, Cardiac fibroma in an infant: single ventricle palliation as a bridge to heart transplantation. The Annals of thoracic surgery. 2003 Apr     [PubMed]
Foulkes WD,Kamihara J,Evans DGR,Brugières L,Bourdeaut F,Molenaar JJ,Walsh MF,Brodeur GM,Diller L, Cancer Surveillance in Gorlin Syndrome and Rhabdoid Tumor Predisposition Syndrome. Clinical cancer research : an official journal of the American Association for Cancer Research. 2017 Jun 15     [PubMed]
Grunau GL,Leipsic JA,Sellers SL,Seidman MA, Cardiac Fibroma in an Adult AIRP Best Cases in Radiologic-Pathologic Correlation. Radiographics : a review publication of the Radiological Society of North America, Inc. 2018 Jul-Aug     [PubMed]
Humez S,Gibier JB,Recher M,Leteurtre S,Leroy X,Devisme L, [Cardiac fibroma: A rare cause of sudden child death]. Annales de pathologie. 2015 Oct     [PubMed]
Cronin B,Lynch MJ,Parsons S, Cardiac fibroma presenting as sudden unexpected death in an adolescent. Forensic science, medicine, and pathology. 2014 Dec     [PubMed]
Zheng XJ,Song B, Left ventricle primary cardiac fibroma in an adult: A case report. Oncology letters. 2018 Oct     [PubMed]
Padalino MA,Vida VL,Boccuzzo G,Tonello M,Sarris GE,Berggren H,Comas JV,Di Carlo D,Di Donato RM,Ebels T,Hraska V,Jacobs JP,Gaynor JW,Metras D,Pretre R,Pozzi M,Rubay J,Sairanen H,Schreiber C,Maruszewski B,Basso C,Stellin G, Surgery for primary cardiac tumors in children: early and late results in a multicenter European Congenital Heart Surgeons Association study. Circulation. 2012 Jul 3     [PubMed]
Elbardissi AW,Dearani JA,Daly RC,Mullany CJ,Orszulak TA,Puga FJ,Schaff HV, Survival after resection of primary cardiac tumors: a 48-year experience. Circulation. 2008 Sep 30     [PubMed]

Disclaimer

The intent of StatPearls is to provide practice questions and explanations to assist you in identifying and resolving knowledge deficits. These questions and explanations are not intended to be a source of the knowledge base of all of medicine, nor is it intended to be a board or certification review of Pediatric. The authors or editors do not warrant the information is complete or accurate. The reader is encouraged to verify each answer and explanation in several references. All drug indications and dosages should be verified before administration.

StatPearls offers the most comprehensive database of free multiple-choice questions with explanations and short review chapters ever developed. This system helps physicians, medical students, dentists, nurses, pharmacists, and allied health professionals identify education deficits and learn new concepts. StatPearls is not a board or certification review system for Pediatric, it is a learning system that you can use to help improve your knowledge base of medicine for life-long learning. StatPearls will help you identify your weaknesses so that when you are ready to study for a board or certification exam in Pediatric, you will already be prepared.

Our content is updated continuously through a multi-step peer review process that will help you be prepared and review for a thorough knowledge of Pediatric. When it is time for the Pediatric board and certification exam, you will already be ready. Besides online study quizzes, we also publish our peer-reviewed content in eBooks and mobile Apps. We also offer inexpensive CME/CE, so our content can be used to attain education credits while you study Pediatric.